|
![]() |
![]() |
![]() |
||||||||
| Corporate
office Phone: +91-79-27680297, 27681895, 27682704, 27680897, 27682708 Fax: +91-79-27682644 E-mail: info@lincolnpharma.com |
Genesis | Profile Mission & Vision Board of Directors Certification Group of Companies Contact Us Plants | Location Tablet & Capsule Section Potential section Liquid & Ointment Section Manufacturing R
& D |
Product
|
Career
|
Feedback
|
|
![]() |
|||||||||
![]() |
Research & Development Right from inception, Lincoln puts a major thrust on developing innovative and technology based products aiming at optimizing the use of drugs for better therapeutic purposes. The R & D center is equipped with sophisticated instruments and equipments for in-house physical, chemical and microbiological analysis of all products. A dedicated group of technocrats mans the R&D center. New product development, Quality improvement in existing products, process development and validation are undertaken here. The ceaseless efforts to develop products by using Optimized Drug Delivery – ensures greater potency & effectiveness, lesser side-effort & toxicity levels, better stability, low cost hence greater accessibility , ease of administration and best patient compliance. Increased patient’s awareness & cutthroat competition amongst the manufacturers induces the company to develop & introduce excellence and novelty in its products. Lincoln’s R&D is keeping pace with the changing pharmaceutical
technology. As a result of focused research, Lincoln has filed patent
for NAMSAFE – a hepato-protective combination of Nimesulide with
Recemethionine and a product patent for the protective combination of
nimsulide with racemethionine and several more patent applications are
in the pipeline. |
||||||||||
|
|||||||||||
:::::
webmaster: imagine communications :::: |
|||||||||||